Trial intelligence / Profile preview

Long-term Study of TS-071 in Combination With Glimepiride in Type 2 Diabetes Mellitus

jRCT2080221468

Sponsor
Taisho Pharmaceutical
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing TS-071 + glimepiride with Placebo + glimepiride (2 arms).

02

Drugs

luseogliflozin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080221468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call